Nov 6 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* INTERIM REPORT JULY-SEPTEMBER 2020
* VICORE PHARMA HOLDING AB - JULY-SEPT NET SALES AMOUNTED TO 0.0 MSEK (0.0)
* VICORE PHARMA HOLDING AB - JULY-SEPT OPERATING LOSS WAS -34.4 MSEK (-22.8)
* VICORE PHARMA HOLDING AB - JULY-SEPT LOSS FOR PERIOD AMOUNTED TO -36.0 MSEK (-22.9)
* VICORE PHARMA HOLDING AB SAYS Q3 WAS CHARACTERIZED BY INTENSE ACTIVITIES, ESPECIALLY
WITHIN
CLINICAL DEVELOPMENT
Source text for Eikon: ID:nWkr9TMx0n
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))